| Financial Year |
March 31 2023 |
| Monetary Funds |
396,766,612.18 |
| Held-for-trading Financial Assets |
9,261,058.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
257,954,460.86 |
| Advances to Suppliers |
13,013,872.54 |
| Other Receivables |
5,392,333.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
201,711,972.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,926,641.89 |
| Total Current Assets |
897,084,360.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,109,090,689.34 |
| Under-construction Projects |
24,460,806.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,746,666.88 |
| R&D expenses |
-- |
| Goodwill |
113,979,999.13 |
| Long-Term Deferred and Prepaid Expenses |
3,969,802.13 |
| Deferred Income Tax Assets |
12,514,433.89 |
| Other Non-Current Assets |
20,000,000.00 |
| Sub-Total of Non-Current Assets |
1,402,762,397.98 |
| Total Assets |
2,299,846,758.36 |
| Short-Term Loans |
22,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
275,882,906.00 |
| Accounts Payable |
315,805,053.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,083,630.83 |
| Taxes Payable |
5,023,864.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,293,060.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,544,697.08 |
| Sub-Total of Current Liabilities |
714,233,479.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,624,242.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
49,176,681.48 |
| Total Liabilities |
763,410,161.21 |
| Paid-In Capital(Or Share Stock) |
178,988,000.00 |
| Capital Surplus |
385,885,011.67 |
| Surplus Reserve |
75,734,345.20 |
| LESS:Treasury Stock |
19,485,060.00 |
| Undistributed Profits |
682,504,617.32 |
| Minority Stockholder's Interest |
232,809,682.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,303,626,914.19 |
| Owner's Equity（Stockholder's Equity） |
1,536,436,597.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,299,846,758.36 |
